Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cann Group ( (AU:CAN) ) has issued an announcement.
Cann Group Limited has announced the closing of its Share Purchase Plan (SPP) Offer today, which allows eligible shareholders to purchase new shares at a discounted price. Each new share comes with an attaching option and a piggyback option, subject to shareholder approval at an upcoming extraordinary general meeting. The board appreciates the support from institutional investors and eligible shareholders, which reflects confidence in the company’s strategic direction and contributes to its growth.
More about Cann Group
Cann Group Limited is a company focused on enhancing patients’ lives through the development, production, and supply of innovative cannabis medicines. It operates research facilities and a large-scale cultivation and GMP manufacturing facility in Victoria, Australia. The company offers a range of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers both in Australia and internationally. Cann Group also owns Satipharm, which features patent-protected capsule technology.
YTD Price Performance: -71.79%
Average Trading Volume: 3,592,294
Technical Sentiment Signal: Sell
Current Market Cap: A$9.13M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.